1
World Health Organization Regional Office for Europe, Copenhagen, Denmark
2
Department of Clinical Pharmacology, The University of Newcastle, Callaghan, NSW, Australia
3
Department of Clinical Pharmacology, University Hospital Rijeka/Medical Faculty and Faculty of Health Studies, University of Rijeka, Rijeka, Croatia
4
European Centre for Disease Prevention and Control, Solna, Sweden
5
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
6
Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
✉*Correspondence: Kotoji Iwamoto, iwamotok@who.int
This article was submitted to Drugs Outcomes Research and Policies, a section of the journal Frontiers in Pharmacology
Copyright ©World Health Organization 2021. Licensee Frontiers Media SA.
This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, adaptation (including derivative works), distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction or adaptation of this article there should not be any suggestion that WHO or this article endorse any specific organisation or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.